---
title: "Sellas Life Sciences (SLS.US) — 财务报表"
type: "Symbol"
locale: "zh-CN"
url: "https://longbridge.com/zh-CN/quote/SLS.US/norm.md"
symbol: "SLS.US"
name: "Sellas Life Sciences"
parent: "https://longbridge.com/zh-CN/quote/SLS.US.md"
datetime: "2026-05-21T21:45:46.958Z"
locales:
  - [en](https://longbridge.com/en/quote/SLS.US/norm.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/SLS.US/norm.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/SLS.US/norm.md)
---

# Sellas Life Sciences (SLS.US) — 财务报表

## 利润表 (USD)

| 指标 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- | --- |
| 每股收益 | -0.0487 | -0.0542 | -0.0626 | -0.0700 | -0.0662 |
| ROE | -37.72% | -52.59% | -75.69% | -97.96% | -124.93% |
| 营业收入 | - | - | - | - | - |
| 净利润 | -8.41M | -7.66M | -6.79M | -6.60M | -5.81M |
| 营业利润 | -9.25M | -7.16M | -7.08M | -6.87M | -6.06M |
| 毛利率 | - | - | - | - | - |
| 净利率 | - | - | - | - | - |
| 利润含金量 | - | - | - | - | - |

## 资产负债表 (USD)

| 指标 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- | --- |
| 资产与负债 | 114.18M | 78.34M | 51.55M | 32.30M | 34.96M |
| 权益乘数 | 1.06 | 1.11 | 1.13 | 1.24 | 1.26 |
| 每股净资产 | 0.5923 | 0.4629 | 0.3648 | 0.2605 | 0.3054 |
| 资产周转率 | - | - | - | - | - |
| 现金及短投 | 107.10M | 71.79M | 44.32M | 25.30M | 28.40M |
| 存货与应收 | - | - | - | - | - |
| 长期投资 | 839000.00 | 963000.00 | 556000.00 | 683000.00 | 806000.00 |
| 净债务 | -106.23M | -70.79M | -43.72M | -24.56M | -27.53M |

## 现金流量表 (USD)

| 指标 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- | --- |
| 经营现金流 | -8.85M | -4.92M | -7.07M | -7.33M | -9.07M |
| 投资现金流 | - | - | - | - | - |
| 融资现金流 | 44.15M | 32.39M | 26.09M | 4.23M | 23.58M |
| 自由现金流 | -6.22M | -1.56M | -4.60M | -5.28M | -7.06M |
| 现金流充裕率 | - | - | - | - | - |
| 举债与偿债 | - | - | - | - | - |
| 资本支出 | - | - | - | - | - |